Presentation purpose:  Lymphedema is swelling caused by the excess buildup of fluid under the skin, and is often caused when lymph nodes are removed or damaged. The lymph nodes act as a filter for waste. Lymphedema is a vastly understudied topic in healthcare, and the treatment is unique and not
provided in standard medical education.

Target audience:
This activity is designed for the interdisciplinary audience including physicians, nursing, pharmacy, PA & Social Workers.


Disclosures:
Faculty: Chad Bowman, PharmD

* Has no relevant financial relationships with ACCME-defined commercial interests
* Will not be discussing the off-label or investigational use of products


Course Chair reviewed and found no Conflict of Interest

All Ascension planners and reviewers have no relevant financial relationships with ACCME-defined commercial interests.

​​​​Q&A:   During this new normal participants will have the ability to send in your question on each topic you view through live streaming to lisa.davis2@ascension.org. Questions and answers will be compiled and sent back out to all participants.  
If you are having trouble viewing the livestream call 205-484-4298 or 205-838-3225


   ​  

         


Presentation 2

Learning Objectives:  

Upon completion of this activity participants should be able to:
● Review the anatomy of the lymphatic system
● Discuss diagnosis and prognosis of lymphedema
● Explore treatment and management of lymphedema

Target audience:
This activity is designed for the interdisciplinary audience including physicians, nursing, pharmacy, PA & Social Workers.


Disclosures:
Faculty: Erica Banner, MSOT, OTR/L, CLT

* Has no relevant financial relationships with ACCME-defined  commercial interests
* Will not be discussing the off-label or investigational use of products


Course Chair reviewed and found no Conflict of Interest

All Ascension planners and reviewers have no relevant financial relationships with ACCME-defined commercial interests.

Presentation purpose:  Through this activity participants will learn more about maximizing patients' benefit from anticoagulation therapy and how they would benefit from early
anticoagulation and determine the appropriate anticoagulation strategy with regard to timing of initiation and agents of choice.

Today's second presentation has been cancelled. 

Presentation 1

Learning Objectives:  

Upon completion of this activity participants should be able to:
● Describe the common indications for the use of warfarin
● Identify the common INR target ranges for these indications
● Discuss the factors that can influence an individuals warfarin dosing
● Discuss the dosing, monitoring, and reversal of alternative oral     anticoagulant agent